Aller au contenu principal
Profil bibliographique

Fenghua Wang

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

74Publications signalées
1204Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Magnesium Alloys: Properties and ApplicationsAluminum Alloys Composites PropertiesRetinal Diseases and TreatmentsAluminum Alloy Microstructure PropertiesGlaucoma and retinal disorders

Les publications récentes

Accès ouvert 2026 erratum OpenAlex

Correction: Engineering of antimicrobial peptide fibrils with feedback degradation of bacterial-secreted enzymes

Fenghua Wang, Wencheng Xia, Mingming Zhang, Rongrong Wu et autres

Correction for ‘Engineering of antimicrobial peptide fibrils with feedback degradation of bacterial-secreted enzymes’ by Fenghua Wang et al. , Chem. Sci. , 2023, 14 , 10914–10924, https://doi.org/10.1039/d3sc01089a.

cn (code pays fourni par la source)

0 citations Chemical Science
Accès ouvert 2025 article OpenAlex

Intravitreal Gene Therapy with LX102-C01 in Neovascular Age-Related Macular Degeneration: A Phase I Dose-Escalation Study of 12-Month Safety and Efficacy Outcomes

Junran Sun, Mengxi Shen, Jieqiong Chen, Yidong Wu et autres

Purpose To assess the safety, tolerability, and preliminary efficacy of a single intravitreal injection of LX102-C01 in eyes with neovascular age-related macular degeneration (nAMD) followed up to 52 weeks. Design Open-label, single-center, dose-escalation investigator-initiated trial (IIT; NCT05831007) with two cohorts (3E10 vg …

cn, us (code pays fourni par la source)

1 citation Ophthalmology Science
Accès ouvert 2025 article OpenAlex

Conformational plasticity of disordered regions enables sequence-diverse DNA recognition by transcription factor AflR

Shaowen Wu, Fenghua Wang, Weijie Zhou, Xinze Zhang et autres

The ability of transcription factors to recognize diverse DNA sequences while maintaining binding specificity is required for gene regulation, but the molecular mechanism enabling this flexibility remains poorly understood. Here, we show that the DNA-binding domain of transcription factor AflR employs a …

cn, de (code pays fourni par la source)

3 citations Nature Communications
Accès ouvert 2025 article OpenAlex

Effect of Al2Y phase on microstructure and deformation behavior of Mg-Al-Y Alloys: Insights from FIB-DIC technique

Zhiyuan Liu, Tianyou Wang, Jin Li, Jian Hua Zeng et autres

In the present work, four Mg-3Al-5Y, Mg-6Al-11Y, Mg-9Al-17Y, and Mg-11Al-21Y (wt.%) alloys, with different volume fractions of Al 2 Y phase, were fabricated by mechanical stirring casting and hot extrusion. The effect of Al 2 Y phase on the microstructure and deformation …

cn (code pays fourni par la source)

2 citations Journal of Magnesium and Alloys
2025 article OpenAlex

Becotatug vedotin vs. chemotherapy in pre-heavily treated advanced nasopharyngeal carcinoma: A randomized, controlled, multicenter, open-label study.

Fei Han, Xiaohui Wang, Yan‐Qun Xiang, Lin‐Quan Tang et autres

LBA6005 Background: Becotatug vedotin (MRG003) is a novel EGFR-targeted antibody-drug conjugate. Previous Phase I/II studies have demonstrated optimistic efficacy in R/M NPC pts who had failed platinum chemotherapy and PD-(L)1 inhibitor. This study aimed to assess clinical efficacy and safety of MRG003 …

cn (code pays fourni par la source)

7 citations Journal of Clinical Oncology
2024 conference-paper OpenAlex

Project-Based Analog Circuit Experiment Design for Lane Detection and Tracking in Electric Trolley Systems

Renjie Hu, Fenghua Wang, Wei Wang, Xuejiao Tang et autres

The traditional experiment projects of circuits fundamentals and analog circuits are often isolated, focusing on individual knowledge points with little correlation between them. These experiments mainly involve circuit validation, lacking innovative project design. As a result, students often struggle to develop a …

cn (code pays fourni par la source)

3 citations
Accès ouvert 2024 conference-abstract OpenAlex

Preliminary results of phase I/II study to evaluate safety and efficacy of combination pucotenlimab with epidermal growth factor receptor-ADC (EGFR-ADC) MRG003 in patients with EGFR positive solid tumors.

Dan‐Yun Ruan, Fei Han, Yujuan Zhou, Fenghua Wang et autres

6013 Background: Pucotenlimab (HX008) is a recombinant humanized PD-1 inhibitor approved for marketing in China, and MRG003 is an EGFR-ADC which has shown promising anti-tumor activity in squamous cell carcinoma of the head and neck (SCCHN) and nasopharyngeal carcinoma (NPC) in multiple …

cn (code pays fourni par la source)

10 citations Journal of Clinical Oncology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.